Cancer News and Research

Latest Cancer News and Research

CBAI collaborates with Center for Stem Cell Awareness to re-sell its stem cell collection and storage services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has contracted with The Center for Stem Cell Awareness to re-sell its stem cell collection and storage services.

19 Jan 2010

PCI Biotech AS completes second dose group in phase I/II study of Amphinex

PCI Biotech AS ( PCIB.OL) reported today that it has completed the successful treatment of the second dose group in the phase I/II study of its proprietary photosensitiser Amphinex® used in combination with the cytotoxic agent bleomycin in cancer patients.

19 Jan 2010

More than half of women with DCIS are spared a mastectomy

Over 60 per cent of women who have a form of breast cancer in the milk ducts (DCIS) are spared a mastectomy, according to latest research published today in the British Journal of Cancer.

19 Jan 2010

Wound Management Technologies engages Miller Tabak to execute its plans for 2010

Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today that it has engaged National Investment Banking firm Miller Tabak & Co., LLC, a twenty-eight year old institutional trading firm as part of its strategy in accelerating the search for potential partners that will help grow revenues, which are necessary to execute Wound Managements plans for 2010.

19 Jan 2010

NorthBay Healthcare selects PHNS to conduct readiness assessment for ICD-10

PHNS Inc. announced that it has been engaged by NorthBay Healthcare (NorthBay), Fairfield, California, to begin the process of assessing its readiness for its migration from ICD-9 to ICD-10. PHNS was awarded this Phase 1 of a multi-phase project for NorthBay.

19 Jan 2010

Findings pave way for designing better antibiotics to target bacterial transcription machinery

A new study led by researchers at NYU Langone Medical Center is shedding new light on the action of Rho, a key regulatory protein in E. coli and many other bacteria.

19 Jan 2010

Multi-lingual breast health booklet introduced for underserved population of women in GTA

Today Willow Breast Cancer Support Canada is announcing the availability of a free, multi-lingual booklet providing culturally appropriate information about breast health practices to a diverse and underserved population of women in the GTA.

19 Jan 2010

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis.

19 Jan 2010

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

More and more Americans with chronic pain not caused by cancer are taking medically prescribed opioids like Oxycontin (oxycodone) and Vicodin (hydrocodone). The January 19 Annals of Internal Medicine features the first study to explore the risk of overdose in patients prescribed opioids for chronic noncancer pain in general health care.

19 Jan 2010

"Nanoburrs" for treating cardiovascular diseases

Researchers at MIT and Harvard Medical School have built targeted nanoparticles that can cling to artery walls and slowly release medicine, an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.

19 Jan 2010

Blocking release of VEGFs may inhibit tumor growth

Researchers at the University of Helsinki, Finland, and the Paul Scherrer Institute (PSI) in Villigen, Switzerland, have determined the crystal structure of the ligand binding domain of a vascular endothelial growth factor (VEGF) receptor in complex with one of its ligands (VEGF-C).

19 Jan 2010

Calsed earns proprietary clinical gold standard status from Decision Resources

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Celgene/Nippon Kayaku's Calsed earns Decision Resources' proprietary clinical gold standard status in 2013 for the treatment of extensive-disease small-cell lung cancer, following its approval for the indication in 2012.

19 Jan 2010

Preventing two oestrogen influencing receptors from 'conversing' may prevent breast cancer

CANCER RESEARCH UK scientists have shown for the first time how preventing two receptors - 'cell antennae' - communicating with each other can influence the activity of oestrogen, the hormone that fuels the progression of breast cancer in many women. The research is published in Genes and Development.

19 Jan 2010

Adverse childhood experiences are associated with increased risk of lung cancer

Adverse events in childhood have been linked to an increase in the likelihood of developing lung cancer in later life. Researchers writing in the open access journal BMC Public Health describe how the link is partly explained by raised rates of cigarette smoking in victims of childhood trauma, but note that other factors may also be to blame.

19 Jan 2010

Unique partnership leverages funds and technology to track and improve breast screening program

The Canadian Breast Cancer Foundation - Atlantic announced today a first-of-its-kind partnership between the breast screening programs of Nova Scotia and Newfoundland and Labrador that yield benefits that could extend to the rest of Canada and beyond.

19 Jan 2010

Huntington Hospital uses Voalte One system to help nurses improve communication at point-of-care

Nationwide, nurse workloads have increased due to higher patient acuity, increased documentation requirements and shortages of staff. Today's nurse finds it more difficult to manage the multiple demands of patients, families and other members of the healthcare team. Put simply, nurses frequently lack the time to do what they joined the profession to do -- provide quality patient care.

19 Jan 2010

Testing for high-risk types of HPV DNA can be effective in preventing invasive cervical cancer

Results from a study of more than 90,000 Italian women published by the Lancet Oncology found that testing for high-risk types of the human papillomavirus (HPV) DNA is significantly more effective in preventing invasive cervical cancer than cytology (Pap testing) alone.

19 Jan 2010

Boehringer Ingelheim, Priaxon announce collaboration in development of mdm2/p53 inhibitors for cancer

Boehringer Ingelheim and Priaxon entered into a worldwide collaboration to research and develop mdm2/p53 inhibitors for the treatment of cancer. Priaxon is providing its innovative and proprietary small molecule drug discovery expertise which is particularly suited to investigate inhibition of protein-protein interactions. p53 is a human tumor suppressor protein.

18 Jan 2010

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

AstraZeneca and Dako Denmark A/S announced today that they have entered into a collaboration agreement to develop companion diagnostic tests for multiple AstraZeneca oncology projects, including biologics and small molecules, in various stages of discovery and development.

18 Jan 2010

Sunlight and vitamin D deficiency linked to 17 varieties of cancer

For humans, sunlight and vitamin D is critically important for the development, growth, and maintenance of a healthy body, from birth until death. "Humans make thousands of units of vitamin D within minutes of whole body exposure to sunlight. From what we know of nature, it is unlikely such a system evolved by chance," states Dr. John Cannell, Executive Director, Vitamin D Council.

18 Jan 2010

Cancer News and Research

Latest Cancer News and Research

CBAI collaborates with Center for Stem Cell Awareness to re-sell its stem cell collection and storage services

PCI Biotech AS completes second dose group in phase I/II study of Amphinex

More than half of women with DCIS are spared a mastectomy

Wound Management Technologies engages Miller Tabak to execute its plans for 2010

NorthBay Healthcare selects PHNS to conduct readiness assessment for ICD-10

Findings pave way for designing better antibiotics to target bacterial transcription machinery

Multi-lingual breast health booklet introduced for underserved population of women in GTA

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

"Nanoburrs" for treating cardiovascular diseases

Blocking release of VEGFs may inhibit tumor growth

Calsed earns proprietary clinical gold standard status from Decision Resources

Preventing two oestrogen influencing receptors from 'conversing' may prevent breast cancer

Adverse childhood experiences are associated with increased risk of lung cancer

Unique partnership leverages funds and technology to track and improve breast screening program

Huntington Hospital uses Voalte One system to help nurses improve communication at point-of-care

Testing for high-risk types of HPV DNA can be effective in preventing invasive cervical cancer

Boehringer Ingelheim, Priaxon announce collaboration in development of mdm2/p53 inhibitors for cancer

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

Sunlight and vitamin D deficiency linked to 17 varieties of cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in